Themis Medicare : Q4 2024 Financial Quarterly Report: YoY Sales Up 22.11 %, QoQ Up 18.55 %

The comprehensive analytics outlining the performance and outlook of Themis Medicare Ltd.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Themis Medicare Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 22.11 %. However, it did see a marginal increase of 18.55 % from the previous quarter. Expenses ticked up slightly by 18.9 % quarter-on-quarter, aligning with the annual rise of 27.15 %. Operating profit, while down -11.34 % compared to last year, faced a quarter-on-quarter increase of 15.38 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.59 %, but a shrinkage of -0.26 % sequentially. Other income fell by -21.38 % compared to the last quarter, despite an annual decline of -12.22 %. Interest expenses dropped significantly by -19.7 % from the previous quarter, yet the year-over-year decrease remains at a moderate -20.3 %. Depreciation costs fell by -1.29 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 9.29 %. Profit before tax declined annually by -15.05 % but saw an increase from the preceding quarter by 6.58 %.
Tax expenses as a percentage of profits increased slightly by 16.86 % compared to last year, with a more notable quarter-on-quarter increase of 10.78 %. Net profit fell by -21.05 % year-on-year but witnessed a -9.91 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -92.11 % but a quarterly fall of -10 %. In summary, Themis Medicare Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Themis Medicare Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 22.11 % year-on-year growth, however, there was a minor increase of 18.55 % from the previous quarter. Expenses rose by 27.15 % compared to the previous year, with a 18.9 % increase quarter-on-quarter. Operating Profit dropped by -11.34 % annually, and saw a 15.38 % increase from the last quarter.
Net Profit showed yearly decrease of -21.05 %, and experienced a -9.91 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -92.11 % annually, however dipped by -10 % compared to the last quarter. In essence, while Themis Medicare Ltd. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.